Systematic review / meta-analysis / 2022
Curcumin supplementation significantly lowered CRP and hs-CRP concentrations in patients with autoinflammatory conditions.
A meta-analysis evaluated the effect of curcumin supplementation on CRP (9 studies) and hs-CRP (23 studies) in patients with autoinflammatory conditions. Curcumin significantly decreased CRP compared to placebo (WMD = -3.67 mg/L, 95% CI = -6.96 to -0.38, p = 0.02), with significant effects at doses ≤1,000 mg/day and interventions >10 weeks. hs-CRP was also significantly lower than placebo, showing significant effects at doses ≤1,000 mg/day and durations ≤10 weeks, reducing hs-CRP in a non-linear fashion with stronger effects at less than 2,000 mg/day.
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- Patients with autoinflammatory conditions (9 studies for CRP, 23 for hs-CRP)
- What was measured
- C-reactive protein (CRP) and high-sensitivity CRP (hs-CRP) concentrations
THE PAPER
Effect of curcumin on C-reactive protein as a biomarker of systemic inflammation: An updated meta-analysis of randomized controlled trials.
Gorabi AM, Abbasifard M, Imani D, Aslani S, Razi B, Alizadeh S, Bagheri-Hosseinabadi Z, Sathyapalan T, Sahebkar A. Phytother Res, 2022.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.